SCHEMBL13927978

SCHEMBL13927978

Nc1nc(NBr)nc2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 16/20 0.69
▸ PIK3CA P42336 2/20 0.69
▸ PIK3CB P42338 2/20 0.69
▸ PIK3CD O00329 1/20 0.69
▸ PIK3C2B O00750 1/20 0.69
▸ PDXK O00764 1/20 0.69
▸ GAK O14976 1/20 0.69
▸ MAP3K7 O43318 1/20 0.69
▸ RIPK2 O43353 1/20 0.69
▸ PIP5K1C O60331 1/20 0.69
▸ STK16 O75716 1/20 0.69
▸ PIK3C2G O75747 1/20 0.69
▸ PRKD3 O94806 1/20 0.69
▸ OXSR1 O95747 1/20 0.69
▸ LATS1 O95835 1/20 0.69
▸ ABL1 P00519 1/20 0.69
▸ EGFR P00533 1/20 0.69
▸ ERBB2 P04626 1/20 0.69
▸ LCK P06239 1/20 0.69
▸ BRAF P15056 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26503858 0.87 PIK3CG (0.69) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29411790 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29506727 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL360279 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL31238338 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29369340 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL29361550 0.82 PIK3CG (1.00) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL3537211 0.81 PIK3CG (0.97) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL3539255 0.81 PIK3CG (0.97) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B
Tg100-115 SCHEMBL3539251 0.81 PIK3CG (0.97) PIK3CGPIK3CAPIK3CBPIK3CDPIK3C2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039683-A2 Vasculostatic agents and methods of use thereof Targegen, Inc. (US) 2009-03-25 — — EP disclosed
Send feedback